104 related articles for article (PubMed ID: 9092812)
1. A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?
Groenen LC; Walker F; Burgess AW; Treutlein HR
Biochemistry; 1997 Apr; 36(13):3826-36. PubMed ID: 9092812
[TBL] [Abstract][Full Text] [Related]
2. Activation of epidermal growth factor receptor by epidermal growth factor.
Sherrill JM; Kyte J
Biochemistry; 1996 May; 35(18):5705-18. PubMed ID: 8639530
[TBL] [Abstract][Full Text] [Related]
3. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
Zhang X; Gureasko J; Shen K; Cole PA; Kuriyan J
Cell; 2006 Jun; 125(6):1137-49. PubMed ID: 16777603
[TBL] [Abstract][Full Text] [Related]
4. Persistence of dimerization and enzymatic activity of epidermal growth factor receptor in the absence of epidermal growth factor.
Tanner KG
Biochemistry; 1997 Dec; 36(48):14889-96. PubMed ID: 9398212
[TBL] [Abstract][Full Text] [Related]
5. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.
Jorissen RN; Epa VC; Treutlein HR; Garrett TP; Ward CW; Burgess AW
Protein Sci; 2000 Feb; 9(2):310-24. PubMed ID: 10716183
[TBL] [Abstract][Full Text] [Related]
7. The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R
Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
[TBL] [Abstract][Full Text] [Related]
8. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto.
Lohmeyer M; Harrison PM; Kannan S; DeSantis M; O'Reilly NJ; Sternberg MJ; Salomon DS; Gullick WJ
Biochemistry; 1997 Apr; 36(13):3837-45. PubMed ID: 9092813
[TBL] [Abstract][Full Text] [Related]
9. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
11. Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.
Ge G; Wu J; Wang Y; Lin Q
Biochem Biophys Res Commun; 2002 Jan; 290(3):914-20. PubMed ID: 11798160
[TBL] [Abstract][Full Text] [Related]
12. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase.
Klingbeil CK; Gill GN
Arch Biochem Biophys; 1999 Mar; 363(1):27-32. PubMed ID: 10049496
[TBL] [Abstract][Full Text] [Related]
13. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of mitogenic pathways through kinase-impaired mutants of the epidermal growth factor receptor.
Ewald JA; Coker KJ; Price JO; Staros JV; Guyer CA
Exp Cell Res; 2001 Aug; 268(2):262-73. PubMed ID: 11478852
[TBL] [Abstract][Full Text] [Related]
15. Rho mediates endocytosis of epidermal growth factor receptor through phosphorylation of endophilin A1 by Rho-kinase.
Kaneko T; Maeda A; Takefuji M; Aoyama H; Nakayama M; Kawabata S; Kawano Y; Iwamatsu A; Amano M; Kaibuchi K
Genes Cells; 2005 Oct; 10(10):973-87. PubMed ID: 16164598
[TBL] [Abstract][Full Text] [Related]
16. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of activation of the tyrosine kinase of a deletion mutant of epidermal growth factor receptor missing the sites of self-phosphorylation.
Sherrill JM; Kyte J
Biochemistry; 1999 Mar; 38(10):3106-11. PubMed ID: 10074364
[TBL] [Abstract][Full Text] [Related]
18. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
Iyer AK; Tran KT; Borysenko CW; Cascio M; Camacho CJ; Blair HC; Bahar I; Wells A
J Cell Physiol; 2007 Jun; 211(3):748-58. PubMed ID: 17311283
[TBL] [Abstract][Full Text] [Related]
19. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
20. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.
Fan YX; Wong L; Johnson GR
Biochem J; 2005 Dec; 392(Pt 3):417-23. PubMed ID: 16122376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
